Clinical Trial Update: Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and efficacy of etrasimod (APD334) in patients with ulcerative colitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Etrasimod (etrasimod)

Snippet

Sponsor: Arena Pharmaceuticals | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2021-04-05